A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/675 (2006.01) A61K 38/19 (2006.01) A61P 21/04 (2006.01) A61P 25/00 (2006.01) A61P 37/00 (2006.01)
Patent
CA 2631760
This disclosure relates, at least in part, to methods of eliminating adverse immune reactions in a subject in need thereof including those associated with autoimmune diseases, allergic reactions and transplant rejection, including administration of a lymphocytotoxic non-myeloablative amount of a oxazaphosphorine drug to the subject.
La présente invention concerne, au moins en partie, des procédés permettant d'éliminer des réactions immunitaires défavorables chez un sujet qui en a besoin, y compris celles associées aux maladies auto-immunes, aux réactions allergiques et aux rejets de greffe. Lesdits procédés incluent l'administration au sujet d'une quantité lymphocytotoxique non myéloablative d'un médicament comprenant de l'oxazaphosphorine.
Brodsky Robert A.
Jones Richard J.
Borden Ladner Gervais Llp
The Johns Hopkins University
LandOfFree
Use of high-dose oxazaphosphorine drugs for treating immune... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of high-dose oxazaphosphorine drugs for treating immune..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of high-dose oxazaphosphorine drugs for treating immune... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1683587